285 related articles for article (PubMed ID: 30073640)
21. Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI.
Guo P; Liu Z; Yan F; Wang J; Wei L; Lv H; Wang Z; Xian J
Acta Radiol; 2016 Dec; 57(12):1490-1496. PubMed ID: 27012277
[TBL] [Abstract][Full Text] [Related]
22. Prognostication of anaplastic astrocytoma patients: application of contrast leakage information of dynamic susceptibility contrast-enhanced MRI and dynamic contrast-enhanced MRI.
Kim HS; Kwon SL; Choi SH; Hwang I; Kim TM; Park CK; Park SH; Won JK; Kim IH; Lee ST
Eur Radiol; 2020 Apr; 30(4):2171-2181. PubMed ID: 31953664
[TBL] [Abstract][Full Text] [Related]
23. Dynamic contrast-enhanced MRI histogram parameters predict progression-free survival in patients with advanced esophageal squamous carcinoma receiving concurrent chemoradiotherapy.
Xu L; Ge X; Sun N; Liu X
Acta Radiol; 2020 Oct; 61(10):1316-1325. PubMed ID: 32053003
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of Primary Central Nervous System Lymphoma From Glioblastoma: Quantitative Analysis Using Arterial Spin Labeling and Diffusion Tensor Imaging.
Abdel Razek AAK; El-Serougy L; Abdelsalam M; Gaballa G; Talaat M
World Neurosurg; 2019 Mar; 123():e303-e309. PubMed ID: 30502475
[TBL] [Abstract][Full Text] [Related]
25. Differentiation between primary CNS lymphoma and glioblastoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
You SH; Yun TJ; Choi HJ; Yoo RE; Kang KM; Choi SH; Kim JH; Sohn CH
Eur Radiol; 2018 Sep; 28(9):3801-3810. PubMed ID: 29619520
[TBL] [Abstract][Full Text] [Related]
26. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.
Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238
[TBL] [Abstract][Full Text] [Related]
27.
Zhou W; Wen J; Hua F; Xu W; Lu X; Yin B; Geng D; Guan Y
Eur J Radiol; 2018 Jul; 104():26-32. PubMed ID: 29857862
[TBL] [Abstract][Full Text] [Related]
28. DCE-MRI-Derived Volume Transfer Constant (K
Ye ZM; Dai SJ; Yan FQ; Wang L; Fang J; Fu ZF; Wang YZ
Technol Cancer Res Treat; 2018 Jan; 17():1533034618765254. PubMed ID: 29642773
[TBL] [Abstract][Full Text] [Related]
29. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS
Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517
[TBL] [Abstract][Full Text] [Related]
30. Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.
Arevalo-Perez J; Kebede AA; Peck KK; Diamond E; Holodny AI; Rosenblum M; Rubel J; Gaal J; Hatzoglou V
J Neuroimaging; 2016 May; 26(3):366-71. PubMed ID: 26707628
[TBL] [Abstract][Full Text] [Related]
31. 18F-FDG PET is an independent outcome predictor in primary central nervous system lymphoma.
Kasenda B; Haug V; Schorb E; Fritsch K; Finke J; Mix M; Hader C; Weber WA; Illerhaus G; Meyer PT
J Nucl Med; 2013 Feb; 54(2):184-91. PubMed ID: 23249539
[TBL] [Abstract][Full Text] [Related]
32. Diffusion and perfusion MRI prediction of progression-free survival in patients with hepatocellular carcinoma treated with concurrent chemoradiotherapy.
Kim KA; Park MS; Ji HJ; Park JY; Han KH; Kim MJ; Kim KW
J Magn Reson Imaging; 2014 Feb; 39(2):286-92. PubMed ID: 24302545
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of Dynamic Contrast-Enhanced MRI-Derived Pharmacokinetic Variables in Glioblastoma Patients: Analysis of Contrast-Enhancing Lesions and Non-Enhancing T2 High-Signal Intensity Lesions.
Kang Y; Hong EK; Rhim JH; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SW; Choi SH
Korean J Radiol; 2020 Jun; 21(6):707-716. PubMed ID: 32410409
[TBL] [Abstract][Full Text] [Related]
34. Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer.
Chen BB; Lu YS; Yu CW; Lin CH; Chen TW; Wei SY; Cheng AL; Shih TT
Eur Radiol; 2018 Nov; 28(11):4860-4870. PubMed ID: 29770848
[TBL] [Abstract][Full Text] [Related]
35. Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
Burth S; Kickingereder P; Eidel O; Tichy D; Bonekamp D; Weberling L; Wick A; Löw S; Hertenstein A; Nowosielski M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
Neuro Oncol; 2016 Dec; 18(12):1673-1679. PubMed ID: 27298312
[TBL] [Abstract][Full Text] [Related]
36. Predictive value of pretreatment MRI texture analysis in patients with primary nasopharyngeal carcinoma.
Mao J; Fang J; Duan X; Yang Z; Cao M; Zhang F; Lu L; Zhang X; Wu X; Ding Y; Shen J
Eur Radiol; 2019 Aug; 29(8):4105-4113. PubMed ID: 30617473
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of microvascular permeability with dynamic contrast-enhanced MRI for the differentiation of primary CNS lymphoma and glioblastoma: radiologic-pathologic correlation.
Kickingereder P; Sahm F; Wiestler B; Roethke M; Heiland S; Schlemmer HP; Wick W; von Deimling A; Bendszus M; Radbruch A
AJNR Am J Neuroradiol; 2014 Aug; 35(8):1503-8. PubMed ID: 24722313
[TBL] [Abstract][Full Text] [Related]
38. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.
Kickingereder P; Wiestler B; Sahm F; Heiland S; Roethke M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
Radiology; 2014 Sep; 272(3):843-50. PubMed ID: 24814181
[TBL] [Abstract][Full Text] [Related]
39. Primary central nervous system lymphoma and glioblastoma differentiation based on conventional magnetic resonance imaging by high-throughput SIFT features.
Chen Y; Li Z; Wu G; Yu J; Wang Y; Lv X; Ju X; Chen Z
Int J Neurosci; 2018 Jul; 128(7):608-618. PubMed ID: 29183170
[TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance texture analysis utility in differentiating intraparenchymal neurosarcoidosis from primary central nervous system lymphoma: a preliminary analysis.
Bathla G; Soni N; Endozo R; Ganeshan B
Neuroradiol J; 2019 Jun; 32(3):203-209. PubMed ID: 30789057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]